
Maxwell
Miner
Senior Researcher, Turku PET Centre
Preclinical Imaging Department Project Manager, PhD
Contact
Links
Publications
New autoradiography image analysis tool combining overlain microscopy and histology in Carimas multimodal DICOM image analysis software (2024)
Annual Congress of the European Association of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging
(Abstrakti)
Evaluation of 18F FOL a PET tracer targeting folate receptor beta in a rat model of myocardial infarction (2024)
ESC Congress, European Heart Journal
(Abstrakti)
High folate receptor expression in gliomas can be detected in vivo using folate-based positron emission tomography with high tumor-to-brain uptake ratio divulging potential future targeting possibilities (2023)
Frontiers in Immunology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Emerging radiopharmaceuticals for PET-imaging gliomas. A multi-: radiopharmaceutical, camera, modality, model, and modelling assessment (2023)
(G5 Artikkeliväitöskirja)Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography (2022)
International Symposium on Radiopharmaceutical Sciences, Nuclear Medicine and Biology
(O2 Muu julkaisu )
Targetting folate receptor-β expressing macrophages by 18F-labelled folate PET radiotracer in rat model of myocardial infarction (2022)
Annual Congress of the European association of nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging
(Vertaisarvioimaton konferenssijulkaisu (B3))
Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-F-18-Fluoroglutamine (2022)
Frontiers in Immunology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Preclinical Evaluation of a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, 89Zr-Desferrioxamine-Bexmarilimab, in a Rabbit Model of Renal Fibrosis (2022)
Journal of Nuclear Medicine
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-18F-Fluoroglutamine(Front. Immunol., (2022), 13, (821423), 10.3389/fimmu.2022.821423) (2022)
Frontiers in Immunology
(O2 Muu julkaisu )
Comparison of: (2S,4R)-4-[F-18]Fluoroglutamine, [C-11]Methionine, and 2-Deoxy-2-[F-18]Fluoro-D-Glucose and Two Small-Animal PET/CT Systems Imaging Rat Gliomas (2021)
Frontiers in Oncology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))